3Zhang DS,Wang DS,Wang ZQ,et al.PhaseⅠ/Ⅱstudy of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients w ith advanced pancreatic cancer[J].Cancer Chemother Pharmacol,2013,71(4):1065-1072.
4Barhoumi M,Mornex F,Bonnetain F,et al.Locally advanced unresectable pancreatic cancer:induction chemoradiotherapy follow ed by maintenance gemcitabine versus gemcitabine alone,definitive results of the 2000—2001 FFCD/SFRO phaseⅢtrial[J].Cancer Radiother,2011,15(3):182-191.
5Loehrer PJ Sr,Feng Y,Cardenes H,et al.Gemcitabine alone versus gemcitabine plus radiotherapy in patients w ith locally advanced pancreatic cancer:an Eastern Cooperative Oncology Group trial[J].J Clin Oncol,2011,29(31):4105-4112.
6Burris HA,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit w ith gemcitabine as first-line therapy for patients w ith advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15(6):2403-2413.
7Humphris JL,Johns AL,Simpson SH,et al.Clinical and pathologic features of familial pancreatic cancer[J].Cancer,2014,120(23):3669-3675.
8Herrmann R,Bodoky G,Ruhstaller T,et al.Gemcitabine plus capecitabine compared w ith gemcitabine alone in advanced pancreatic cancer:a randomized,multicenter,phaseⅢtrial of the Sw iss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group[J].J Clin Oncol,2007,25(16):2212-2217.
9Ueno H,Ioka T,Ikeda M,et al.Randomized phase III study of gemcitabine plus S-1,S-1 alone,or gemcitabine alone in patients w ith locally advanced and metastatic pancreatic cancer in Japan and Taiw an:GEST study[J].J Clin Oncol,2013,31(13):1640-1648.
10Desai N,Trieu V,Yao Z,et al.Increased antitumor activity,intratumor paclitaxel concentrations,and endothelial cell transport of cremophor-free,albumin-bound paclitaxel,ABI-007,compared w ith cremophor-based paclitaxel[J].Clin Cancer Res,2006,12(4):1317-1324.
